203 related articles for article (PubMed ID: 21376746)
1. Selectivity and potency of the retroprogesterone dydrogesterone in vitro.
Rižner TL; Brožič P; Doucette C; Turek-Etienne T; Müller-Vieira U; Sonneveld E; van der Burg B; Böcker C; Husen B
Steroids; 2011 May; 76(6):607-15. PubMed ID: 21376746
[TBL] [Abstract][Full Text] [Related]
2. Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3.
Beranič N; Gobec S; Rižner TL
Chem Biol Interact; 2011 May; 191(1-3):227-33. PubMed ID: 21182831
[TBL] [Abstract][Full Text] [Related]
3. Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins.
Beranič N; Brožič P; Brus B; Sosič I; Gobec S; Lanišnik Rižner T
J Steroid Biochem Mol Biol; 2012 May; 130(1-2):16-25. PubMed ID: 22245609
[TBL] [Abstract][Full Text] [Related]
4. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Beranič N; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
[TBL] [Abstract][Full Text] [Related]
5. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
6. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
[TBL] [Abstract][Full Text] [Related]
7. Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities.
Bydal P; Luu-The V; Labrie F; Poirier D
Eur J Med Chem; 2009 Feb; 44(2):632-44. PubMed ID: 18472187
[TBL] [Abstract][Full Text] [Related]
8. Compound profiling using a panel of steroid hormone receptor cell-based assays.
Wilkinson JM; Hayes S; Thompson D; Whitney P; Bi K
J Biomol Screen; 2008 Sep; 13(8):755-65. PubMed ID: 18753690
[TBL] [Abstract][Full Text] [Related]
9. Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells.
Simoncini T; Caruso A; Giretti MS; Scorticati C; Fu XD; Garibaldi S; Baldacci C; Mannella P; Fornari L; Genazzani AR
Fertil Steril; 2006 Oct; 86(4 Suppl):1235-42. PubMed ID: 16963030
[TBL] [Abstract][Full Text] [Related]
10. 3Beta-alkyl-androsterones as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: inhibitory potency in intact cells, selectivity towards isoforms 1, 2, 5 and 7, binding affinity for steroid receptors, and proliferative/antiproliferative activities on AR+ and ER+ cell lines.
Ngatcha BT; Laplante Y; Labrie F; Luu-The V; Poirier D
Mol Cell Endocrinol; 2006 Mar; 248(1-2):225-32. PubMed ID: 16359782
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive progestins. Various 11-substituents combined with four 17-substituents: 17alpha-ethynyl, five- and six-membered spiromethylene ethers or six-membered spiromethylene lactones.
Schoonen WG; Deckers G; de Gooijer ME; de Ries R; Mathijssen-Mommers G; Hamersma H; Kloosterboer HJ
J Steroid Biochem Mol Biol; 2000 Oct; 74(3):109-23. PubMed ID: 11086230
[TBL] [Abstract][Full Text] [Related]
12. Biotechnological production of 20-alpha-dihydrodydrogesterone at pilot scale.
Naumann JM; Zöllner A; Drăgan CA; Messinger J; Adam J; Bureik M
Appl Biochem Biotechnol; 2011 Sep; 165(1):190-203. PubMed ID: 21494755
[TBL] [Abstract][Full Text] [Related]
13. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
14. Progestins inhibit expression of MMPs and of angiogenic factors in human ectopic endometrial lesions in a mouse model.
Mönckedieck V; Sannecke C; Husen B; Kumbartski M; Kimmig R; Tötsch M; Winterhager E; Grümmer R
Mol Hum Reprod; 2009 Oct; 15(10):633-43. PubMed ID: 19671596
[TBL] [Abstract][Full Text] [Related]
15. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays.
Fuhrmann U; Slater EP; Fritzemeier KH
Contraception; 1995 Jan; 51(1):45-52. PubMed ID: 7750284
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 7α-methyl-19-nortestosterone effectiveness alone or combined with progestins on androgen receptor mediated-transactivation.
García-Becerra R; Ordaz-Rosado D; Noé G; Chávez B; Cooney AJ; Larrea F
Reproduction; 2012 Feb; 143(2):211-9. PubMed ID: 22065861
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of chlormadinone acetate and its 3alpha- and 3beta-hydroxy metabolites on progesterone, androgen and glucocorticoid receptors.
Schneider J; Kneip C; Jahnel U
Pharmacology; 2009; 84(2):74-81. PubMed ID: 19590256
[TBL] [Abstract][Full Text] [Related]
19. Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules.
Fu XD; Garibaldi S; Gopal S; Polak K; Palla G; Spina S; Mannella P; Genazzani AR; Genazzani AD; Simoncini T
Mol Hum Reprod; 2012 Jan; 18(1):44-51. PubMed ID: 21971309
[TBL] [Abstract][Full Text] [Related]
20. Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.
Teulings FA; van Gilse HA; Henkelman MS; Portengen H; Alexieva-Figusch J
Cancer Res; 1980 Jul; 40(7):2557-61. PubMed ID: 6248208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]